Paul Joannes Van Diest

Paul Joannes Van Diest's AcademicInfluence.com Rankings

Biology

#16399

Historical Rank

Molecular Biology

#2160

Historical Rank

biology Degrees

Download Badge

Biology

Paul Joannes Van Diest's Degrees

PhD Molecular Biology Stanford University

Why Is Paul Joannes Van Diest Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Paul Joannes Van Diest's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinoma (2003) (522)
An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity (2019) (377)
Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. (2008) (350)
Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. (2002) (327)
Digital pathology: current status and future perspectives (2012) (304)
Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer. (2005) (299)
Metalloprotease ADAM10 Is Required for Notch1 Site 2 Cleavage* (2009) (268)
Plasticity between Epithelial and Mesenchymal States Unlinks EMT from Metastasis-Enhancing Stem Cell Capacity (2016) (256)
Molecular signature associated with bone marrow micrometastasis in human breast cancer. (2003) (239)
Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin. (2000) (231)
The origin of vimentin expression in invasive breast cancer: epithelial–mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential? (2005) (226)
Receptor conversion in distant breast cancer metastases (2010) (209)
Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene. (2003) (200)
BRCA1 and BRCA2 germline mutation analysis in the Indonesian population (2007) (196)
Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study (2016) (191)
Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops (1998) (187)
Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations. (2000) (187)
The molecular genetics and morphometry‐based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system (2005) (181)
Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review. (2009) (180)
c-Jun activation is associated with proliferation and angiogenesis in invasive breast cancer. (2006) (179)
Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. (2000) (165)
Hypoxia‐inducible factor‐1α is associated with angiogenesis, and expression of bFGF, PDGF‐BB, and EGFR in invasive breast cancer (2005) (165)
Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis (2018) (163)
Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution (2001) (159)
Rapid Visualization of Human Tumor Xenografts through Optical Imaging with a Near-Infrared Fluorescent Anti–Epidermal Growth Factor Receptor Nanobody (2012) (156)
Targeting DDX3 with a small molecule inhibitor for lung cancer therapy (2015) (155)
Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model (2005) (153)
Primary Colorectal Cancers and Their Subsequent Hepatic Metastases Are Genetically Different: Implications for Selection of Patients for Targeted Treatment (2011) (144)
Twist contributes to hormone resistance in breast cancer by down-regulating estrogen receptor alpha (2011) (141)
Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer (2011) (141)
Hypoxic regulation of metastasis via hypoxia-inducible factors. (2008) (140)
HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor (2005) (132)
BRCA1/2-related ovarian cancers are of tubal origin: a hypothesis. (2003) (128)
Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast (2000) (123)
HIF-1 alpha expression is associated with an atheromatous inflammatory plaque phenotype and upregulated in activated macrophages. (2007) (121)
Cytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistance. (2011) (120)
COMMD1 disrupts HIF-1alpha/beta dimerization and inhibits human tumor cell invasion. (2010) (114)
Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high‐resolution microarray comparative genomic hybridization (2003) (110)
Patient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug Responses. (2019) (105)
EGFR targeted nanobody–photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer (2016) (101)
Methylation of the TWIST1 Promoter, TWIST1 mRNA Levels, and Immunohistochemical Expression of TWIST1 in Breast Cancer (2008) (93)
Analysis of the progression of fibroepithelial tumours of the breast by PCR‐based clonality assay (2002) (89)
Prognostic value of estrogen receptor α and progesterone receptor conversion in distant breast cancer metastases (2012) (85)
Accelerated Perinecrotic Outgrowth of Colorectal Liver Metastases Following Radiofrequency Ablation is a Hypoxia-Driven Phenomenon (2009) (84)
Ultrasound-Guided Laser-Induced Thermal Therapy for Small Palpable Invasive Breast Carcinomas: A Feasibility Study (2009) (81)
Vascular endothelial growth factor-165 overexpression stimulates angiogenesis and induces cyst formation and macrophage infiltration in human ovarian cancer xenografts. (2002) (81)
First clinical experience with a dedicated MRI-guided high-intensity focused ultrasound system for breast cancer ablation (2016) (76)
Validation of a gene expression signature for assessment of lymph node metastasis in oral squamous cell carcinoma. (2012) (76)
Expression of hypoxia-inducible factor-1α and cell cycle proteins in invasive breast cancer are estrogen receptor related (2004) (76)
The role of hypoxia inducible factor-1alpha in gynecological cancer. (2011) (75)
Ovarian carcinogenesis: an alternative hypothesis. (2008) (75)
Reduced cilia frequencies in human renal cell carcinomas versus neighboring parenchymal tissue (2013) (74)
The peptidyl-isomerase Pin1 regulates p27kip1 expression through inhibition of Forkhead box O tumor suppressors. (2008) (73)
Pathological characterisation of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. (2017) (73)
Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study (2011) (69)
Differential Notch and TGFβ Signaling in Primary Colorectal Tumors and Their Corresponding Metastases (2008) (69)
Radioactive seed localization for non‐palpable breast cancer (2013) (68)
Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study (2004) (67)
Nuclear localization of the transcriptional coactivator YAP is associated with invasive lobular breast cancer (2013) (67)
Epigenetics in ovarian cancer. (2012) (67)
A whole‐genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor‐negative and ‐positive breast cancers (2012) (65)
Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer (2015) (64)
Pitfalls in immunohistochemical assessment of EGFR expression in soft tissue sarcomas (2006) (62)
Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. (2005) (61)
PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients (2014) (61)
HER-2/neu Testing and Therapy in Gastroesophageal Adenocarcinoma (2010) (60)
Expression of proliferation and apoptosis-related proteins in usual ductal hyperplasia of the breast. (1998) (59)
Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplification (2012) (59)
Formaldehyde substitute fixatives: effects on nucleic acid preservation (2011) (59)
Hypoxia and Angiogenesis in Endometrioid Endometrial Carcinogenesis (2007) (58)
HER-2/neu Amplification Testing in Breast Cancer by Multiplex Ligation-Dependent Probe Amplification in Comparison with Immunohistochemistry and In Situ Hybridization (2008) (58)
Balance of cell proliferation and apoptosis in breast carcinogenesis (1999) (58)
Molecular markers predict outcome in squamous cell carcinoma of the head and neck after concomitant cisplatin‐based chemoradiation (2009) (57)
Necrosis related HIF-1α expression predicts prognosis in patients with endometrioid endometrial carcinoma (2010) (57)
Low frequency of HER2 amplification and overexpression in early onset gastric cancer (2011) (56)
Nuclear Kaiso Expression Is Associated with High Grade and Triple-Negative Invasive Breast Cancer (2012) (56)
Perinecrotic hypoxia contributes to ischemia/reperfusion-accelerated outgrowth of colorectal micrometastases. (2007) (55)
Targeting RNA helicases in cancer: The translation trap. (2017) (54)
Active HIF-1 in the Normal Human Retina (2010) (54)
Promoter hypermethylation in male breast cancer: analysis by multiplex ligation-dependent probe amplification (2012) (54)
Methylation profiles of hereditary and sporadic ovarian cancer (2010) (54)
p300 and p53 levels determine activation of HIF-1 downstream targets in invasive breast cancer. (2006) (53)
COMMD1 Promotes pVHL and O2-Independent Proteolysis of HIF-1α via HSP90/70 (2009) (53)
E-cadherin loss induces targetable autocrine activation of growth factor signalling in lobular breast cancer (2018) (52)
Reduced Growth, Increased Vascular Area, and Reduced Response to Cisplatin in CD13-Overexpressing Human Ovarian Cancer Xenografts (2004) (52)
Expression of the RNA Helicase DDX3 and the Hypoxia Response in Breast Cancer (2013) (52)
A novel method to quantify IRDye800CW fluorescent antibody probes ex vivo in tissue distribution studies (2012) (51)
Expression of BNIP3 in invasive breast cancer: correlations with the hypoxic response and clinicopathological features (2009) (51)
Interplay between VHL/HIF1alpha and Wnt/beta-catenin pathways during colorectal tumorigenesis. (2006) (51)
Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment (2012) (50)
Loss of p120-catenin induces metastatic progression of breast cancer by inducing anoikis resistance and augmenting growth factor receptor signaling. (2013) (50)
HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation (2014) (50)
Fallopian Tube Intraluminal Tumor Spread From Noninvasive Precursor Lesions: A Novel Metastatic Route in Early Pelvic Carcinogenesis (2013) (49)
Hypoxia-Targeting Fluorescent Nanobodies for Optical Molecular Imaging of Pre-Invasive Breast Cancer (2015) (48)
Mutation Profiling of Key Cancer Genes in Primary Breast Cancers and Their Distant Metastases. (2018) (48)
Expression Pattern of a Homeotic Gene, HOXA5, in Normal Breast and in Breast Tumors (2006) (48)
RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3. (2016) (47)
Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment (2017) (47)
Progressive derailment of cell cycle regulators in endometrial carcinogenesis (2007) (47)
Frequent discordance in PD-1 and PD-L1 expression between primary breast tumors and their matched distant metastases (2018) (46)
Clinical and genetic evaluation of thirty ovarian cancer families. (1998) (46)
Oncogenic KRAS desensitizes colorectal tumor cells to epidermal growth factor receptor inhibition and activation. (2010) (46)
The invasive front in endometrial carcinoma: higher proliferation and associated derailment of cell cycle regulators. (2007) (45)
Functional antibodies produced by oncolytic clostridia. (2007) (45)
HER-2/neu amplification testing in breast cancer by Multiplex Ligation-dependent Probe Amplification: influence of manual- and laser microdissection (2009) (45)
Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer (2018) (45)
Loss of expression of FANCD2 protein in sporadic and hereditary breast cancer (2007) (44)
Optical imaging of pre-invasive breast cancer with a combination of VHHs targeting CAIX and HER2 increases contrast and facilitates tumour characterization (2016) (44)
Expression of differentiation and proliferation related proteins in epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition (2003) (43)
Epidermal Growth Factor Receptor Expression in High-Grade Osteosarcomas Is Associated with a Good Clinical Outcome (2007) (43)
Validation of tissue microarray technology in squamous cell carcinoma of the esophagus (2008) (43)
Expression and localization of hypoxia proteins in prostate cancer: prognostic implications after radical prostatectomy. (2009) (43)
Contemporary risks of local and regional recurrence and contralateral breast cancer in patients treated for primary breast cancer. (2016) (42)
High frequency of HIF-1alpha overexpression in BRCA1 related breast cancer. (2008) (41)
mTOR in squamous cell carcinoma of the oesophagus: a potential target for molecular therapy? (2008) (40)
Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivo (2008) (40)
Preoperative sentinel node mapping with (99m)Tc-nanocolloid SPECT-CT significantly reduces the intraoperative sentinel node retrieval time in robot assisted laparoscopic cervical cancer surgery. (2013) (40)
Accuracy of contrast-enhanced breast ultrasound for pre-operative tumor size assessment in patients diagnosed with invasive ductal carcinoma of the breast (2007) (39)
Genomic evolution from primary breast carcinoma to distant metastasis: Few copy number changes of breast cancer related genes. (2014) (39)
Giant cell formation in sarcoidosis: cell fusion or proliferation with non‐division? (2009) (38)
Radio guided occult lesion localization (ROLL) for non‐palpable invasive breast cancer (2008) (38)
Multiple fibroadenomas harbouring carcinoma in situ in a woman with a family history of breast/ovarian cancer (2002) (38)
Population based study on sentinel node biopsy before or after neoadjuvant chemotherapy in clinically node negative breast cancer patients: Identification rate and influence on axillary treatment. (2015) (37)
Deciphering a subgroup of breast carcinomas with putative progression of grade during carcinogenesis revealed by comparative genomic hybridisation (CGH) and immunohistochemistry (2004) (37)
Discrimination between benign and malignant prostate tissue using chromatin texture analysis in 3‐D by confocal laser scanning microscopy (2007) (37)
Expression of nuclear FIH independently predicts overall survival of clear cell renal cell carcinoma patients. (2010) (36)
Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast Cancer. (2016) (36)
Molecular profile of ductal carcinoma in situ of the breast in BRCA1 and BRCA2 germline mutation carriers (2009) (35)
Comparative Histomorphological Review of Rat and Human Hepatocellular Proliferative Lesions (2012) (35)
Methylation profiles of endometrioid and serous endometrial cancers. (2010) (34)
Immunophenotyping of male breast cancer (2012) (34)
Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer (2011) (34)
Radiofrequency ablation for breast cancer: a review of the literature. (2007) (33)
Upregulation of Claudin-4, CAIX and GLUT-1 in distant breast cancer metastases (2014) (33)
Amide chemical exchange saturation transfer at 7 T: a possible biomarker for detecting early response to neoadjuvant chemotherapy in breast cancer patients (2018) (33)
Comparison of Different Promoter Methylation Assays in Breast Cancer (2010) (33)
Correlation of morphologic and cytogenetic parameters of genetic instability with chromosomal alterations in in situ carcinomas of the breast. (2000) (33)
Serum CA-125 in relation to adnexal dysplasia and cancer in women at hereditary high risk of ovarian cancer. (2007) (32)
HIF-1α Overexpression in Ductal Carcinoma In Situ of the Breast in BRCA1 and BRCA2 Mutation Carriers (2013) (32)
Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer (2002) (32)
FANCD2 protein is expressed in proliferating cells of human tissues that are cancer‐prone in Fanconi anaemia (2003) (32)
Incomplete thermal ablation stimulates proliferation of residual renal carcinoma cells in a translational murine model (2012) (32)
Lobulitis is a frequent finding in prophylactically removed breast tissue from women at hereditary high risk of breast cancer (2005) (32)
Alterations in the p53 pathway and prognosis in advanced ovarian cancer: a multi-factorial analysis of the EORTC Gynaecological Cancer group (study 55865). (2006) (32)
Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective (2009) (31)
Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors (2013) (31)
Aberrant expression of muc1 mucin in ductal hyperplasia and ductal carcinoma In situ of the breast (1999) (31)
ESR1 amplification is rare in breast cancer and is associated with high grade and high proliferation: a multiplex ligation-dependent probe amplification study (2011) (31)
Nuclear morphometric features in benign breast tissue and risk of subsequent breast cancer (2006) (31)
Expression of Growth Factors, Growth Factor Receptors and Apoptosis Related Proteins in Invasive Breast Cancer: Relation to Apoptotic Rate (2001) (30)
Targets for molecular therapy in esophageal squamous cell carcinoma: an immunohistochemical analysis. (2009) (30)
Evolution of the Ablation Region After Magnetic Resonance–Guided High-Intensity Focused Ultrasound Ablation in a Vx2 Tumor Model (2013) (30)
Characterization of ex vivo healthy human axillary lymph nodes with high resolution 7 Tesla MRI (2010) (30)
Low prevalence of (pre) malignant lesions in the breast and high prevalence in the ovary and Fallopian tube in women at hereditary high risk of breast and ovarian cancer (2006) (30)
Molecular Analysis of Nipple Fluid for Breast Cancer Screening (2008) (30)
p16 is Consistently Expressed in Endometrial Tubal Metaplasia (2007) (30)
Protein expression of B-cell lymphoma gene 6 (BCL-6) in invasive breast cancer is associated with cyclin D1 and hypoxia-inducible factor-1alpha (HIF-1alpha). (2003) (30)
Prognostic significance of the EGFR pathway in nasopharyngeal carcinoma: a systematic review and meta-analysis. (2015) (30)
BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers (2017) (29)
Systematic review and meta‐analysis of the diagnostic accuracy of ductoscopy in patients with pathological nipple discharge (2016) (29)
No Amplifications of Hypoxia-Inducible Factor-1α Gene in Invasive Breast Cancer: A Tissue Microarray Study (2004) (28)
Significant inter‐ and intra‐laboratory variation in grading of invasive breast cancer: A nationwide study of 33,043 patients in the Netherlands (2019) (28)
Aberrant expression of MUC1 mucin in ductal hyperplasia and ductal carcinoma In situ of the breast. (1999) (28)
Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast (2005) (28)
Conditional Inactivation of HIF-1 Using Intrabodies (2008) (28)
Prediction of positive resection margins in patients with non-palpable breast cancer. (2015) (28)
Redefining radiotherapy for early-stage breast cancer with single dose ablative treatment: a study protocol (2017) (28)
Cytokeratin and protein expression patterns in squamous cell carcinoma of the oral cavity provide evidence for two distinct pathogenetic pathways (2016) (28)
Recruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131* (2016) (28)
Global transcriptional analysis identifies a novel role for SOX4 in tumor-induced angiogenesis (2018) (27)
A Novel Diagnostic Tool for Selecting Patients With Mesenchymal-Type Colon Cancer Reveals Intratumor Subtype Heterogeneity. (2017) (27)
The molecular genetic make-up of male breast cancer. (2019) (27)
Fibroblast growth factor receptor 3 protein is overexpressed in oral and oropharyngeal squamous cell carcinoma (2015) (27)
Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session (2020) (27)
Radiofrequency ablation of colorectal liver metastases induces an inflammatory response in distant hepatic metastases but not in local accelerated outgrowth (2010) (27)
PI3K/AKT/mTOR pathway activation in primary and corresponding metastatic breast tumors after adjuvant endocrine therapy (2014) (27)
Implementation of a Multicenter Biobanking Collaboration for Next-Generation Sequencing-Based Biomarker Discovery Based on Fresh Frozen Pretreatment Tumor Tissue Biopsies. (2017) (27)
Implications of rarity of chromosome 17 polysomy in breast cancer. (2011) (27)
The significance of the HER-2 status in esophageal adenocarcinoma for survival: an immunohistochemical and an in situ hybridization study. (2013) (27)
Cyclooxygenase-2 is a target of KRASD12, which facilitates the outgrowth of murine C26 colorectal liver metastases. (2005) (26)
Cannabinoid receptor-2 immunoreactivity is associated with survival in squamous cell carcinoma of the head and neck. (2013) (26)
The 3-layered Ductal Epithelium in Gynecomastia (2012) (26)
T cell infiltration and MHC I and II expression in the presence of tumor antigens: An immunohistochemical study in patients with serous epithelial ovarian cancer. (2001) (26)
HER-family gene amplification and expression in resected pancreatic cancer. (2009) (26)
Cathepsin K associates with lymph node metastasis and poor prognosis in oral squamous cell carcinoma (2018) (25)
Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33 (2018) (25)
αE‐catenin is a candidate tumor suppressor for the development of E‐cadherin‐expressing lobular‐type breast cancer (2018) (25)
Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging (2020) (25)
Immunophenotyping invasive breast cancer: paving the road for molecular imaging (2012) (25)
Progressive APOBEC3B mRNA expression in distant breast cancer metastases (2017) (25)
Promoter hypermethylation using 24-gene array in early head and neck cancer (2014) (25)
A systematic review on the frequency of BRCA promoter methylation in breast and ovarian carcinomas of BRCA germline mutation carriers: Mutually exclusive, or not? (2018) (25)
CYP2C19*2 predicts substantial tamoxifen benefit in postmenopausal breast cancer patients randomized between adjuvant tamoxifen and no systemic treatment (2013) (25)
Hypoxia-Inducible Factor-1 as a Therapeutic Target in Endometrial Cancer Management (2010) (25)
Why prostate tumour delineation based on apparent diffusion coefficient is challenging: An exploration of the tissue microanatomy (2013) (25)
Sex matters: men with melanoma have a worse prognosis than women (2019) (24)
Unravelling site-specific breast cancer metastasis: a microRNA expression profiling study (2016) (24)
Bone metastasis treatment using magnetic resonance-guided high intensity focused ultrasound. (2015) (24)
Survival analysis in familial ovarian cancer, a case control study. (2001) (23)
Site-specific gene expression patterns in oral cancer (2017) (23)
Significant inter- and intra-laboratory variation in grading of ductal carcinoma in situ of the breast: a nationwide study of 4901 patients in the Netherlands (2018) (23)
Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis (2021) (23)
Genomic Profiling by Array Comparative Genomic Hybridization Reveals Novel DNA Copy Number Changes in Breast Phyllodes Tumours (2008) (23)
HIF-1A gene mutations associated with higher microvessel density in endometrial carcinomas. (2008) (22)
DNA promoter hypermethylation in nipple fluid: a potential tool for early breast cancer detection (2016) (22)
Fibroblast Growth Factor Receptor Family Members as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review (2015) (22)
The prognostic effect of DDX3 upregulation in distant breast cancer metastases (2016) (22)
Radiofrequency ablation of small breast tumours: evaluation of a novel bipolar cool-tip application. (2014) (22)
Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases (2014) (22)
Pathology of hereditary breast cancer (2011) (22)
Prognostic modeling of oral cancer by gene profiles and clinicopathological co-variables (2017) (22)
Subcellular FIH-1 expression patterns in invasive breast cancer in relation to HIF-1α expression (2011) (21)
Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017 (2020) (21)
Differential Expression of Growth Factor Receptors and Membrane-Bound Tumor Markers for Imaging in Male and Female Breast Cancer (2013) (21)
Humoral immune responses to MUC1 in women with a BRCA1 or BRCA2 mutation. (2007) (21)
Mutation analysis of the HIF-1alpha oxygen-dependent degradation domain in invasive breast cancer. (2005) (20)
Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer (2017) (20)
miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers (2015) (20)
Interventional ductoscopy in patients with pathological nipple discharge (2015) (20)
Moral Duties of Genomics Researchers: Why Personalized Medicine Requires a Collective Approach. (2017) (20)
The potential of hypoxia markers as target for breast molecular imaging – a systematic review and meta-analysis of human marker expression (2013) (20)
Differences between hereditary and sporadic ovarian cancer. (1999) (20)
Re: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. (2004) (20)
Meta‐analysis of the concordance of histological grade of breast cancer between core needle biopsy and surgical excision specimen (2016) (20)
Progressive deregulation of the cell cycle with higher tumor grade in the stroma of breast phyllodes tumors. (2005) (20)
Serous Borderline Tumor of the Ovary Presenting With Cervical Lymph Node Involvement: A Report of 3 Cases (2006) (19)
ESR1 Amplification is Rare in Breast Cancer and is Associated with High Grade and High Proliferation: A Multiplex Ligation-Dependent Probe Amplification Study (2010) (19)
Lympho-vascular invasion in BRCA related breast cancer compared to sporadic controls (2010) (19)
Risk Biomarker Assessment for Breast Cancer Progression: Replication Precision of Nuclear Morphometry (2003) (19)
HER‐2/neu and p27Kip1 in progression of Fallopian tube carcinoma: an immunohistochemical and array comparative genomic hybridization study (2007) (19)
FGFR4 Is a Potential Predictive Biomarker in Oral and Oropharyngeal Squamous Cell Carcinoma (2015) (19)
SlideToolkit: An Assistive Toolset for the Histological Quantification of Whole Slide Images (2014) (19)
Global Effects of DDX3 Inhibition on Cell Cycle Regulation Identified by a Combined Phosphoproteomics and Single Cell Tracking Approach (2018) (18)
Successful oxytocin-assisted nipple aspiration in women at increased risk for breast cancer (2010) (18)
Egfr Amplification Specific Gene Expression in Phyllodes Tumours of the Breast (2007) (18)
Progression risk of columnar cell lesions of the breast diagnosed in core needle biopsies (2011) (18)
FGFR Family Members Protein Expression as Prognostic Markers in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma (2016) (18)
Chromosome 16q loss--a genetic key to the understanding of breast carcinogenesis. (2013) (18)
FOXA1 levels are decreased in pleural breast cancer metastases after adjuvant endocrine therapy, and this is associated with poor outcome (2018) (18)
Spatial collagen stiffening promotes collective breast cancer cell invasion by reinforcing extracellular matrix alignment (2022) (17)
Effects of magnetic resonance-guided high-intensity focused ultrasound ablation on bone mechanical properties and modeling (2015) (17)
Early detection of changes in phospholipid metabolism during neoadjuvant chemotherapy in breast cancer patients using phosphorus magnetic resonance spectroscopy at 7T (2019) (17)
Cleavage of Notch1 by granzyme B disables its transcriptional activity. (2011) (17)
p53 mutations in classic and pleomorphic invasive lobular carcinoma of the breast (2012) (17)
Expression of HIF-1α in medullary thyroid cancer identifies a subgroup with poor prognosis (2017) (16)
Evaluation of the HER2 amplification status in oesophageal adenocarcinoma by conventional and automated FISH: a tissue microarray study (2013) (16)
Correlation of cyclin D1 and Rb gene expression with apoptosis in invasive breast cancer. (1998) (16)
Regulation of E2F1 by the von Hippel–Lindau tumour suppressor protein predicts survival in renal cell cancer patients (2013) (16)
Sentinel lymph node localization with contrast-enhanced ultrasound and an I-125 seed: an ideal prospective development study. (2015) (16)
Methylation-Specific Multiplex Ligation-Dependent Probe Amplification (MS-MLPA). (2018) (16)
Validation of a Fully Automated HER2 Staining Kit in Breast Cancer (2010) (16)
DDX3 has divergent roles in head and neck squamous cell carcinomas in smoking versus non-smoking patients. (2015) (16)
Women harboring BRCA1/2 germline mutations are at risk for breast and female adnexal carcinoma. (2003) (15)
ESR1 Amplification in Breast Cancer by Optimized RNase FISH: Frequent but Low-Level and Heterogeneous (2013) (15)
p120-catenin prevents multinucleation through control of MKLP1-dependent RhoA activity during cytokinesis (2016) (15)
Phase I feasibility study of Magnetic Resonance guided High Intensity Focused Ultrasound-induced hyperthermia, Lyso-Thermosensitive Liposomal Doxorubicin and cyclophosphamide in de novo stage IV breast cancer patients: study protocol of the i-GO study (2020) (15)
Exploring Gene Expression Signatures for Predicting Disease Free Survival after Resection of Colorectal Cancer Liver Metastases (2012) (15)
Rocky road to digital diagnostics: implementation issues and exhilarating experiences (2020) (14)
Ovarian carcinogenesis, an alternative theory. (2007) (14)
Chromosome 17 Polysomy without HER2 Amplification Does Not Predict Response to Lapatinib in Metastatic Breast Cancer—Letter (2010) (14)
FANCD2 expression in advanced non-small-cell lung cancer and response to platinum-based chemotherapy. (2005) (14)
Repeated Nipple Fluid Aspiration: Compliance and Feasibility Results from a Prospective Multicenter Study (2015) (14)
Cultures of ovarian surface epithelium from women with and without a hereditary predisposition to develop female adnexal carcinoma. (2004) (14)
Long‐term survival of T1 and T2 lymph node‐negative breast cancer patients according to mitotic activity index: A population‐based study (2006) (13)
Optimal adjuvant endocrine treatment of ER+/HER2+ breast cancer patients by age at diagnosis: A population-based cohort study. (2018) (13)
Promoter hypermethylation profiling of distant breast cancer metastases (2015) (13)
Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study (2020) (13)
Investigation of lipid composition of dissected sentinel lymph nodes of breast cancer patients by 7T proton MR spectroscopy (2012) (13)
5th International Symposium on Focused Ultrasound (2016) (13)
Chromosome 17 copy number changes in male breast cancer (2015) (13)
Hormone- and HER2-receptor assessment in 33,046 breast cancer patients: a nationwide comparison of positivity rates between pathology laboratories in the Netherlands (2019) (13)
Multiplex Ligation-Dependent Probe Amplification to Detect HER2 Amplification in Breast Cancer: New Insights in Optimal Cut-Off Value (2010) (13)
The Co-Expression of Kallikrein 5 and Kallikrein 7 Associates with Poor Survival in Non-HPV Oral Squamous-Cell Carcinoma (2015) (13)
Artificial intelligence applied to breast pathology (2021) (12)
Brief Fixation Does Not Affect Assessment of Hormone Receptor Expression in Invasive Breast Carcinoma Biopsies: Paving the Road for Same-day Tissue Diagnostics (2014) (12)
Methylation biomarkers for pleomorphic lobular breast cancer - a short report (2015) (12)
Increased Levels of Oxidative Damage in Liver Metastases Compared with Corresponding Primary Colorectal Tumors: Association with Molecular Subtype and Prior Treatment. (2018) (12)
EGFR Expression Predicts BRCA1 Status in Patients with Breast Cancer (2006) (12)
Expression of Connective Tissue Growth Factor in Male Breast Cancer: Clinicopathologic Correlations and Prognostic Value (2015) (12)
Reverse proteomic antibody screening identifies anti adhesive VHH targeting VLA-3. (2009) (12)
Secretome proteomics reveals candidate non-invasive biomarkers of BRCA1 deficiency in breast cancer (2016) (12)
Near-Infrared Fluorescence Molecular Imaging of Ductal Carcinoma In Situ with CD44v6-Specific Antibodies in Mice: A Preclinical Study (2012) (11)
Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy (2022) (11)
Interventional Ductoscopy as an Alternative for Major Duct Excision or Microdochectomy in Women Suffering Pathologic Nipple Discharge: A Single-center Experience. (2020) (11)
Micrometastases and isolated tumor cells in breast cancer are indeed associated with poorer outcome. (2010) (11)
The effect of an e-learning module on grading variation of (pre)malignant breast lesions (2020) (10)
The theranostic target prostate-specific membrane antigen is expressed in medullary thyroid cancer. (2018) (10)
Hypoxia inducible NOD2 interacts with 3-O-sulfogalactoceramide and regulates vesicular homeostasis. (2013) (10)
Molecular profile of nasopharyngeal carcinoma: analysing tumour suppressor gene promoter hypermethylation by multiplex ligation-dependent probe amplification (2017) (10)
A novel BRCA2 mutation in an Indonesian family found with a new, rapid, and sensitive mutation detection method based on pooled denaturing gradient gel electrophoresis and targeted sequencing (2005) (10)
Prognostic Value of Mitotic Index and Bcl2 Expression in Male Breast Cancer (2013) (10)
Copy number changes at 8p11-12 predict adverse clinical outcome and chemo- and radiotherapy response in breast cancer (2018) (10)
Mitotic count can predict tamoxifen benefit in postmenopausal breast cancer patients while Ki67 score cannot (2018) (10)
Copy number profiling by array comparative genomic hybridization identifies frequently occurring BRCA2‐like male breast cancer (2015) (10)
ABC-Transporter Expression Does Not Correlate with Response to Irinotecan in Patients with Metastatic Colorectal Cancer (2015) (10)
Antimitotic agents for the treatment of patients with metastatic castrate-resistant prostate cancer (2013) (10)
Promoter hypermethylation patterns in fallopian tube epithelium of BRCA1 and BRCA2 germ line mutation carriers. (2012) (10)
Variation in breast cancer grading: the effect of creating awareness through laboratory-specific and pathologist-specific feedback reports in 16 734 patients with breast cancer (2020) (9)
Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells (2013) (9)
SSTR2A expression in medullary thyroid carcinoma is correlated with longer survival (2018) (9)
Pathology issues related to SN procedures and increased detection of micrometastases and isolated tumor cells. (2010) (9)
v-Raf Murine Sarcoma Viral Oncogene Mutation Status in Serous Borderline Ovarian Tumors and the Effect on Clinical Behavior (2009) (9)
Impact of preoperative evaluation of tumour grade by core needle biopsy on clinical risk assessment and patient selection for adjuvant systemic treatment in breast cancer (2015) (9)
Diagnostic Accuracy of Radioactive Iodine Seed Placement in the Axilla With Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer. (2022) (9)
PD-1 and PD-L1 Expression in Male Breast Cancer in Comparison with Female Breast Cancer (2018) (8)
Inter‐observer agreement for the histological diagnosis of invasive lobular breast carcinoma (2021) (8)
Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort study (2017) (8)
Methylation Profile of X-Chromosome–Related Genes in Male Breast Cancer (2020) (8)
The Prognostic and Clinical Value of Morphometry and DNA Cytometry in Borderline Ovarian Tumors: A Prospective Study (2009) (8)
Prospects of Targeting the Gastrin Releasing Peptide Receptor and Somatostatin Receptor 2 for Nuclear Imaging and Therapy in Metastatic Breast Cancer (2017) (8)
Role of DDX3 in the pathogenesis of inflammatory bowel disease (2017) (8)
Detection of breast cancer precursor lesions by autofluorescence ductoscopy (2020) (8)
Deep learning-based grading of ductal carcinoma in situ in breast histopathology images (2020) (8)
The mucinous variant of columnar cell lesions (2011) (8)
Epigenetic biomarkers in the diagnosis of ovarian cancer. (2012) (8)
Working toward consensus among professionals in the identification of classical cervical cytomorphological characteristics in whole slide images (2015) (7)
The effects of Magnetic Resonance Imaging-guided High-Intensity Focused Ultrasound ablation on human cadaver breast tissue. (2013) (7)
Deep learning-based breast cancer grading and survival analysis on whole-slide histopathology images (2022) (7)
Low Levels of BNIP3 Promoter Hypermethylation in Invasive Breast Cancer (2010) (7)
An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity (2019) (7)
Predicting turnaround time reductions of the diagnostic track in the histopathology laboratory using mathematical modelling (2016) (7)
Clinical Significance and Molecular Annotation of Cellular Morphometric Subtypes in Lower Grade Gliomas discovered by Machine Learning. (2022) (7)
Loss of steroid hormone receptors is common in malignant pleural and peritoneal effusions of breast cancer patients treated with endocrine therapy. (2017) (7)
Copy number profiling of oncogenes in ductal carcinoma in situ of the male breast. (2017) (7)
CEP17 copy number increase does not indicate polysomy 17 (2014) (7)
Testing for discordance at metastatic relapse of breast cancer matters. (2012) (7)
Conventional Pathology Versus Gene Signatures for Assessing Luminal A and B Type Breast Cancers: Results of a Prospective Cohort Study (2018) (7)
Genomic aberrations relate early and advanced stage ovarian cancer (2012) (7)
Role of columnar cell lesions in breast carcinogenesis: analysis of chromosome 16 copy number changes by multiplex ligation-dependent probe amplification (2018) (7)
Lessons Learned from Setting Up a Prospective, Longitudinal, Multicenter Study with Women at High Risk for Breast Cancer (2020) (6)
Correlation between E-cadherin and p120 expression in invasive ductal breast cancer with a lobular component and MRI findings (2017) (6)
Performance of 4 Immunohistochemical Phosphohistone H3 Antibodies for Marking Mitotic Figures in Breast Cancer (2016) (6)
Promoter hypermethylation in ductal carcinoma in situ of the male breast. (2019) (6)
Twist activates miR-22 to suppress estrogen receptor alpha in breast cancer (2021) (6)
Grading variation in 2,934 patients with ductal carcinoma in situ of the breast: the effect of laboratory- and pathologist-specific feedback reports (2020) (6)
Loss of steroid hormone receptors is common in malignant pleural and peritoneal effusions of breast cancer patients treated with endocrine therapy (2017) (6)
Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients (2021) (6)
Application of Nipple Aspirate Fluid miRNA Profiles for Early Breast Cancer Detection and Management (2019) (6)
Tales of How Great Drugs Were Brought Down by a Flawed Rationale—Letter (2013) (6)
Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer (2022) (5)
St. Gallen endocrine response classes predict recurrence rates over time. (2015) (5)
Re: How do you tell whether a breast cancer is HER2 positive? Ongoing studies keep debate in high gear. (2011) (5)
Expression of hypoxia-induced proteins in ductal carcinoma in situ and invasive cancer of the male breast (2019) (5)
The diagnostic process of cervical cancer; areas of good practice, and windows of opportunity. (2015) (4)
Ethical considerations for modern molecular pathology (2018) (4)
Validity of whole slide images for scoring HER2 chromogenic in situ hybridisation in breast cancer (2016) (4)
Signal transduction pathway activity in high-grade serous carcinoma, its precursors and Fallopian tube epithelium. (2022) (4)
Validation of digital microscopy: Review of validation methods and sources of bias (2021) (4)
Imaging to predict checkpoint inhibitor outcomes in cancer. A systematic review. (2022) (4)
Book review on “digital pathology”: Historical perspectives, current concepts, & future applications (2016) (4)
Interobserver Agreement of PD-L1/SP142 Immunohistochemistry and Tumor-Infiltrating Lymphocytes (TILs) in Distant Metastases of Triple-Negative Breast Cancer: A Proof-of-Concept Study. A Report on Behalf of the International Immuno-Oncology Biomarker Working Group (2021) (4)
Intraductal cisplatin treatment in a BRCA-associated breast cancer mouse model attenuates tumor development but leads to systemic tumors in aged female mice (2017) (4)
Cytoplasmic DDX3 as prognosticator in male breast cancer (2021) (4)
The microRNA Lifecycle in Health and Cancer (2022) (4)
The Physiological MicroRNA Landscape in Nipple Aspirate Fluid: Differences and Similarities with Breast Tissue, Breast Milk, Plasma and Serum (2020) (4)
A case of loss of heterozygosity in the BRCA2 gene of a borderline ovarian tumor: case report and review of literature (2006) (4)
Thick melanomas without lymph node metastases: A forgotten group with poor prognosis. (2019) (3)
Implementation of Artificial Intelligence in Diagnostic Practice as a Next Step after Going Digital: The UMC Utrecht Perspective (2022) (3)
The changing microRNA landscape by color and cloudiness: a cautionary tale for nipple aspirate fluid biomarker analysis (2021) (3)
Comprehensive Proteomic Profiling–derived Immunohistochemistry-based Prediction Models for BRCA1 and BRCA2 Germline Mutation-related Breast Carcinomas (2018) (3)
Nipple Aspirate Fluid at a Glance (2021) (3)
Concurrent versus sequential use of trastuzumab and chemotherapy in early HER2+ breast cancer (2020) (3)
The increasing importance of histologic grading in tailoring adjuvant systemic therapy in 30,843 breast cancer patients (2021) (3)
DYSPLASTIC CHANGES IN PROPHYLACTICALLY REMOVED FALLOPIAN TUBES OF WOMEN PREDISPOSED TO DEVELOP OVARIAN/FALLOPIAN TUBE CANCER (2003) (3)
Meta-analysis and cost-effectiveness of ductoscopy, duct excision surgery and MRI for the diagnosis and treatment of patients with pathological nipple discharge (2021) (3)
Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer (2022) (3)
Intraductal cisplatin treatment in a BRCA-associated breast cancer mouse model attenuates tumor development but leads to systemic tumors in aged female mice. (2017) (3)
Heterogeneity in Signaling Pathway Activity within Primary and between Primary and Metastatic Breast Cancer (2020) (2)
Prognostic models in male breast cancer (2016) (2)
Improving prediction of response to neoadjuvant treatment in patients with breast cancer by combining liquid biopsies with multiparametric MRI: protocol of the LIMA study – a multicentre prospective observational cohort study (2022) (2)
Intraoperative MET-receptor targeted fluorescent imaging and spectroscopy for lymph node detection in papillary thyroid cancer: novel diagnostic tools for more selective central lymph node compartment dissection (2022) (2)
Lack of association between CDKN2A germline mutations and survival in melanoma patients: a retrospective cohort study. (2021) (2)
Amplification testing in breast cancer by multiplex ligation-dependent probe amplification of microdissected tissue. (2011) (2)
Molecular Differences between Ductal Carcinoma In Situ and Adjacent Invasive Breast Carcinoma: A Multiplex Ligation-Dependent Probe Amplification Study (2010) (2)
Interlaboratory Gleason grading variation affects treatment: a Dutch historic cohort study in 30 509 patients with prostate cancer (2022) (1)
It takes two to Twist. (2009) (1)
Corrigendum: p120-catenin prevents multinucleation through control of MKLP1-dependent RhoA activity during cytokinesis (2017) (1)
BRCA1 methylation and BRCA1 mutations in ovarian cancer. (2011) (1)
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group (2021) (1)
Value of routine cytokeratin immunohistochemistry in detecting low volume disease in cervical cancer. (2022) (1)
Receptor Status of Breast Cancer Diagnosed during Pregnancy: A Literature Review. (2021) (1)
Predicting recurrence in patients with sentinel node-negative melanoma: validation of the EORTC nomogram using population-based data. (2021) (1)
Breast Cancer and Major Deviations of Genetic and Gender-related Structures and Function. (2020) (1)
Superficial basal cell carcinoma, think deeper: Step sectioning of skin biopsy specimens yields 14% more aggressive subtypes (2022) (1)
Metalloprotease ADAM10 is required for Notch1 site 2 cleavage. (2010) (1)
Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment (2014) (1)
Upregulation of Claudin-4, CAIX and GLUT-1 in distant breast cancer metastases (2014) (1)
Re: Clarke et al. Cytokeratin 5/6 in normal human breast: lack of evidence for a stem cell phenotype. J Pathol 2004;204:147–152 (2005) (1)
Correspondence (1872) (1)
Pigmented villonodular synovitis: an overdiagnosed entity (2009) (1)
Analytical Validation of a Novel 6-Gene Signature for Prediction of Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative, Early-Stage Breast Cancer. (2022) (1)
Blunt duct adenosis: a separate entity from columnar cell lesions? (2021) (1)
Deep Learning-Based Segmentation of Locally Advanced Breast Cancer on MRI in Relation to Residual Cancer Burden: A Multiinstitutional Cohort Study. (2023) (1)
Array comparative genomic hybridization analysis indicates that serous carcinomas of the ovary, fallopian tube and endometrium are distinct entities (2010) (1)
COMPARISON OF OVARIAN SURFACE EPITHELIUM IN PRIMARY CULTURE FROM WOMEN WITH AND WITHOUT A HEREDITARY PREDISPOSITION TO DEVELOP OVARIAN/TUBAL CARCINOMA (2003) (1)
Frequent discordance in PD-1 and PD-L1 expression between primary breast tumors and their matched distant metastases (2018) (1)
Patients’ perceptions of 70-gene signature testing: commonly changing the initial inclination to undergo or forego chemotherapy and reducing decisional conflict (2020) (1)
Cyclic activity of signal transduction pathways in fimbrial epithelium of the human fallopian tube (2021) (1)
A whole‐slide imaging based workflow reduces the reading time of pathologists (2021) (1)
Promoter hypermethylation in male breast cancer: analysis by multiplex ligation-dependent probe amplification (2012) (0)
The CONFIDENT-P trial: Clinical implementation of artificial intelligence assistance in prostate cancer pathology. (2023) (0)
HER2 testing recommendations in the UK: dual- or single-colour in-situ hybridisation? (2011) (0)
Methylation biomarkers for pleomorphic lobular breast cancer - a short report (2015) (0)
The potential of hypoxia markers as target for breast molecular imaging – a systematic review and meta-analysis of human marker expression (2013) (0)
PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients (2014) (0)
p53 mutations in classic and pleomorphic invasive lobular carcinoma of the breast (2012) (0)
Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma (2023) (0)
Tumor cell dyscohesion in carcinoma of the breast. (1998) (0)
Nuclear localization of the transcriptional coactivator YAP is associated with invasive lobular breast cancer (2013) (0)
Deep learning-based grading of ductal carcinoma in situ in breast histopathology images. (2021) (0)
Response to A. Matikas et al. (2018) (0)
PROPHYLACTIC SURGERY IN WOMEN AT HIGH RISK FOR BREAST AND/OR OVARIAN/TUBAL CANCER (2003) (0)
E-cadherin loss induces targetable autocrine activation of growth factor signalling in lobular breast cancer (2018) (0)
0082: Serum Ca-125 in Relation to (PRE) Malignant Adnexal Lesions in Women at Hereditary High Risk of Ovarian Cancer (2006) (0)
Comparative immunohistochemical investigation of rat and human hepatocellular carcinomas (2013) (0)
Dimorphic cells: a common feature throughout the low nuclear grade breast neoplasia spectrum (2022) (0)
Validation of DNA promoter hypermethylation biomarkers in breast cancer — a short report (2014) (0)
IHC-based Ki67 as response biomarker to tamoxifen in breast cancer window trials enrolling premenopausal women (2021) (0)
Correction: ESR1 Amplification in Breast Cancer by Optimized RNase FISH: Frequent but Low-Level and Heterogeneous (2014) (0)
Patient-reported outcomes of ductoscopy procedures for pathologic nipple discharge (2020) (0)
Re: the Association between hysterectomy and ovarian cancer risk: A population-based record-linkage study. (2019) (0)
Cathepsin K associates with lymph node metastasis and poor prognosis in oral squamous cell carcinoma (2018) (0)
00069 BORDERLINE OVARIAN TUMOURS; MORPHOMETRIC FEATURES DO NOT PREDICT CLINICAL BEHAVIOUR (2005) (0)
Elevated miR-29c-5p Expression in Nipple Aspirate Fluid Is Associated with Extremely High Mammographic Breast Density (2022) (0)
True extent of calcifying DCIS components of invasive breast cancer: radiological-pathological correlation in slice radiograms of breast conserving therapy specimens (2019) (0)
Chromosome 17 copy number changes in male breast cancer (2015) (0)
Mammatumoren (2020) (0)
IHC-based Ki67 as response biomarker to tamoxifen in breast cancer window trials enrolling premenopausal women (2021) (0)
Are St. Gallen endocrine response classes predictive for recurrence rates over time? (2011) (0)
Authors' reply (2005) (0)
The prognostic effect of DDX3 upregulation in distant breast cancer metastases (2016) (0)
Prophylaxis of hereditary breast cancer (2017) (0)
Use of the ISUP e-learning module improves interrater reliability in prostate cancer grading (2022) (0)
HIF-1α and NOTCH signaling in ductal and lobular carcinomas of the breast (2012) (0)
Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer (2018) (0)
Analysis of expression of membrane-bound tumor markers in ductal carcinoma in situ of the breast: paving the way for molecular imaging (2013) (0)
Amide chemical exchange saturation transfer at 7 T: a possible biomarker for detecting early response to neoadjuvant chemotherapy in breast cancer patients (2018) (0)
BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers (2017) (0)
Abstract P1-02-09: Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer (ILC) (2022) (0)
Mitotic count can predict tamoxifen benefit in postmenopausal breast cancer patients while Ki67 score cannot (2018) (0)
Immunophenotyping invasive breast cancer: paving the road for molecular imaging (2012) (0)
COMPARISON OF PROTEIN-EXPRESSION IN SEROUS FALLOPIAN TUBE CARCINOMA AND SEROUS OVARIAN CARCINOMA; CLUES TO A SIMILAR PATHOGENESIS (2003) (0)
In Reply to Tsoutsou. (2021) (0)
Analysis of gene copy number alterations by multiplex ligation-dependent probe amplification in columnar cell lesions of the breast (2014) (0)
Patient-centered research: how do women tolerate nipple fluid aspiration as a potential screening tool for breast cancer? (2022) (0)
Serous carcinogenesis: a classic causality dilemma or which came first... ? (2014) (0)
Pregnancy-associated breast cancer: the influence of gestational age. (2021) (0)
Abstract 3937: An intracellular variant of zona pellucida glycoprotein 3 is expressed in cancer (2023) (0)
Plain Language Summary - Development and validation of risk calculators for people with "thin" melanomas on their skin to predict the likelihood that their cancer will return. (2023) (0)
Male breast cancer (2018) (0)
Idiopathic granulomatous mastitis after ductoscopy: A case report (2021) (0)
Patient-centered research: how do women tolerate nipple fluid aspiration as a potential screening tool for breast cancer? (2022) (0)
FGFR Family Members Protein Expression as Prognostic Markers in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma (2016) (0)
Correction: Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer (2022) (0)
[Patient with Peutz-Jeghers syndrome and liver metastases from an unknown primary tumor]. (2000) (0)
Fluorescently labeled bevacizumab in human breast cancer: defining the classification threshold (2017) (0)
Lobular Breast Cancer: Pathology, Biology, and Options for Clinical Intervention (2013) (0)
Genomic aberrations relate early and advanced stage ovarian cancer (2012) (0)
Abstract P3-12-06: Prognosis of pregnancy-associated breast cancer: Inferior outcome in patients diagnosed during second and third gestational trimesters and lactation (2022) (0)
A novel rapid and sensitive BRCA1/2 mutation detection method based on pooled DGGE and targeted sequencing (2006) (0)
Primary colorectal tumors and their metastasis are genetically not the same: Implications for choice of targeted treatment? (2011) (0)
Papillomatous breast lesions with atypical columnar cell features (2023) (0)
Unique Case of a Rare Mesenchymal Tumor Harboring a Somatic c.119delC VHL Mutation. (2019) (0)
PROGNOSTIC FACTORS IN BORDERLINE OVARIAN TUMOURS (2004) (0)
CT radiomics compared to a clinical model for predicting checkpoint inhibitor treatment outcomes in patients with advanced melanoma. (2023) (0)
000174 HYPOXIA-INDUCIBLE FACTOR-1α AND GLUT-1 EXPRESSION IN HYPERPLASIA AND ENDOMETRIAL CANCER (2005) (0)
NTRK rearrangements in a subset of NF1-related malignant peripheral nerve sheath tumors as novel actionable target (2022) (0)

This paper list is powered by the following services:

Paul Joannes Van Diest's Academic­Influence.com Rankings

Paul Joannes Van Diest's Degrees

Why Is Paul Joannes Van Diest Influential?

Paul Joannes Van Diest's Published Works

Published Works

Paul Joannes Van Diest's AcademicInfluence.com Rankings